| Literature DB >> 25041441 |
Nada Müller1, Raphaël Moëne, José A Cancela, Andrea Mombelli.
Abstract
OBJECTIVES: To evaluate repeated subgingival air-polishing in residual pockets with a new erythritol powder containing 0.3% chlorhexidine.Entities:
Keywords: air-polishing; clinical trial; maintenance; subgingival plaque removal
Mesh:
Substances:
Year: 2014 PMID: 25041441 PMCID: PMC4287198 DOI: 10.1111/jcpe.12289
Source DB: PubMed Journal: J Clin Periodontol ISSN: 0303-6979 Impact factor: 8.728
Figure 1Erythritol powder containing 0.3% chlorhexidine (Air Flow® Powder PLUS).
Figure 2Subgingival air-polishing in a residual pocket, using a special nozzle (test).
Clinical baseline characteristics of all 6918 monitored sites by treatment
| Test side | Control side | ||
|---|---|---|---|
| 70.9 (11.7) | 72.5 (11.2) | n.s. | |
| 4.6 (5.6) | 4.8 (5.2) | n.s. | |
| PlI, score 0–3 | 0.4 (0.2) | 0.4 (0.2) | n.s. |
| PD, mm | 2.8 (0.3) | 2.8 (0.3) | n.s. |
| BOP+, % | 22 (10) | 21 (10) | n.s. |
| REC, mm | 0.9 (0.7) | 0.9 (0.7) | n.s. |
Data are means (SD) per patient (n = 50).
PlI, Plaque Index; PD, probing pocket depth; BOP+, bleeding on probing; REC, recession.
Baseline characteristics of the study sites (in each participant the site with the deepest PD on the test and control side, n = 50 sites on each side)
| Test site | Control site | ||
|---|---|---|---|
| PD, mm | 5.2 (0.4) | 5.4 (0.6) | 0.003 |
| BOP+, % | 58 (50) | 48 (50) | n.s. |
| REC, mm | 1.0 (0.9) | 0.9 (1.0) | n.s. |
| Root hypersensitivity, mm VAS | 22.2 (27.4) | 21.2 (21.2) | n.s. |
| AA >1000; >100,000 | 7; 1 | 7; 0 | n.s.; n.s. |
| BF >1000; >100,000 | 37; 20 | 39; 15 | n.s.; n.s. |
| PG >1000; >100,000 | 37; 14 | 37; 12 | n.s.; n.s. |
| TD >1000; >100,000 | 42; 22 | 42; 27 | n.s.; n.s. |
| PI >1000; >100,000 | 20; 8 | 14; 6 | n.s.; n.s. |
| PM >1000; >100,000 | 44; 19 | 49; 23 | n.s.; n.s. |
Clinical data are means (SD), microbiological data are numbers of sites positive with counts >1000 and >100,000.
PD, probing pocket depth; BOP+, bleeding on probing; AA, Aggregatibacter actinomycetemcomitans; BF, Tannerella forsythia; PG, Porphyromonas gingivalis; TD, Treponema denticola; PI, Prevotella intermedia; PM, Parvimonas micra.
Clinical characteristics at month 12 of 6750 monitored sites by treatment
| Test side | Control side | ||
|---|---|---|---|
| 70.9 (11.8) | 72.6 (11.3) | n.s. | |
| 3.6 (5.8) | 3.9 (6.2) | n.s. | |
| PlI, score 0–3 | 0.3 (0.1) | 0.3 (0.1) | n.s. |
| PD, mm | 2.8 (0.5) | 2.7 (0.5) | n.s. |
| BOP+, % | 15 (6) | 14 (6) | n.s. |
| REC, mm | 0.9 (0.7) | 0.9 (0.7) | n.s. |
Data are means (SD) per patient (n = 49).
PlI, Plaque Index; PD, probing pocket depth; BOP+, bleeding on probing; REC, recession.
Status of the study sites at month 12 (in each participant the site with the deepest PD on the test and control side, n = 49 sites on each side)
| Test site | Control site | ||
|---|---|---|---|
| PD, mm | 4.5 (1.0) | 4.4 (1.1) | n.s. |
| BOP+, % | 31 (47) | 27 (45) | n.s. |
| REC, mm | 1.0 (1.0) | 0.8 (1.1) | n.s. |
| Root hypersensitivity, mm VAS | 21.3 (23.0) | 16.6 (17.8) | n.s. |
| AA >1000; >100,000 | 3; 0 | 10; 2 | 0.035; n.s. |
| BF >1000; >100,000 | 35; 18 | 35; 19 | n.s.; n.s. |
| PG >1000; >100,000 | 33; 9 | 34; 10 | n.s.; n.s. |
| TD >1000; >100,000 | 36; 21 | 38; 17 | n.s.; n.s. |
| PI >1000; >100,000 | 17; 4 | 11; 4 | n.s.; n.s. |
| PM >1000; >100,000 | 41; 19 | 41; 16 | n.s.; n.s. |
Clinical data are means (SD), microbiological data are numbers of sites positive with counts >1000 and >100,000.
PD, probing pocket depth; BOP+, bleeding on probing; AA, Aggregatibacter actinomycetemcomitans; BF, Tannerella forsythia; PG, Porphyromonas gingivalis; TD, Treponema denticola; PI, Prevotella intermedia; PM, Parvimonas micra.